Lyka Labs Limited (NSE:LYKALABS)
India
· Delayed Price · Currency is INR 57.50
+0.43 (0.75%)
Mar 10, 2026, 10:00 AM IST
Lyka Labs Revenue
Lyka Labs had revenue of 307.28M INR in the quarter ending December 31, 2025, a decrease of -9.08%. This brings the company's revenue in the last twelve months to 1.30B, up 1.90% year-over-year. In the fiscal year ending March 31, 2025, Lyka Labs had annual revenue of 1.35B with 27.04% growth.
Revenue (ttm)
1.30B
Revenue Growth
+1.90%
P/S Ratio
1.56
Revenue / Employee
2.61M
Employees
499
Market Cap
2.04B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 1.35B | 287.16M | 27.04% |
| Mar 31, 2024 | 1.06B | 167.66M | 18.75% |
| Mar 31, 2023 | 894.17M | -950.50M | -51.53% |
| Mar 31, 2022 | 1.84B | 1.16B | 169.25% |
| Mar 31, 2021 | 685.11M | 118.05M | 20.82% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Haleos Labs | 3.48B |
| TAKE Solutions | -70.53M |
| Panacea Biotec | 6.06B |
| Dishman Carbogen Amcis | 27.97B |
| Zota Health Care | 4.73B |
| Supriya Lifescience | 7.35B |
| Blue Jet Healthcare | 10.53B |
| Concord Biotech | 11.59B |
Lyka Labs News
- 7 months ago - Lyka Labs shares fall 3% as Q1 net profit falls 20% YoY; Check earnings - Business Upturn
- 11 months ago - Lyka Labs secures patent for Pregabalin Gel 8% to treat diabetic neuropathic pain - Business Upturn